Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/20040833 below:

Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population

Affiliations

• ¹ 1i3 Innovus, Eden Prairie, MN 55344, USA. henry.henk@i3innovus.com

• PMID: 20040833
• DOI: 10.1097/LGT.0b013e3181ac05e9

Item in Clipboard

Henry J Henk et al. J Low Genit Tract Dis. 2010 Jan.

• ¹ 1i3 Innovus, Eden Prairie, MN 55344, USA. henry.henk@i3innovus.com

• PMID: 20040833
• DOI: 10.1097/LGT.0b013e3181ac05e9

Item in Clipboard

Objective: This study aimed to estimate incidence, cost per episode of care, and US population burden of cervical intraepithelial neoplasia (CIN).

Materials and methods: For women continuously enrolled in a US health plan from January 1, 1999 to December 31, 2004, medical claims were used to identify potential CIN diagnosis. Presence and grade of CIN (CIN 1, CIN 2,3, or no CIN) were verified in medical records for a randomly selected subset (n = 254). Incidence, costs, and population burden were calculated.

Results: Annual incidence for CIN 1 and CIN 2,3 was 1.6 and 1.2 per 1,000 women, respectively. Incidence was highest among women aged 21 to 30 years (3.3 and 3.6 per 1,000) and women aged 31 to 40 years (2.9 and 2.7 per 1,000). Costs per episode of care were higher for CIN 2,3 ($1,634 vs $1,084). Estimated annual burden per 1,000 US women was $1,059 for CIN 1 and $1,803 for CIN 2,3.

Conclusions: We estimate that 412,000 women in the United States are diagnosed with CIN annually, with an associated cost of approximately $570 million.

PubMed Disclaimer

• Incidence and costs of cervical intraepithelial neoplasia in the Korean population.

  Chang HK, Seo SS, Myong JP, Yu YL, Byun SW. Chang HK, et al. J Gynecol Oncol. 2019 May;30(3):e37. doi: 10.3802/jgo.2019.30.e37. J Gynecol Oncol. 2019. PMID: 30887758 Free PMC article.

• Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain.

  Castellsagué X, Rémy V, Puig-Tintoré LM, de la Cuesta RS, Gonzalez-Rojas N, Cohet C. Castellsagué X, et al. J Low Genit Tract Dis. 2009 Jan;13(1):38-45. doi: 10.1097/LGT.0b013e318182cd89. J Low Genit Tract Dis. 2009. PMID: 19098605

• Resource Use and Cost of Treating Human Papillomavirus-Related Lesions in Japanese Women.

  Mizukami A, Kaise T, Van Kriekinge G. Mizukami A, et al. Value Health Reg Issues. 2018 May;15:56-62. doi: 10.1016/j.vhri.2017.07.009. Epub 2017 Sep 1. Value Health Reg Issues. 2018. PMID: 29474179

• Incidence of cervical intraepithelial neoplasia in Estonia.

  Uusküla A, Raag M, Uppin A, Raud T, Klaar U, Jürisson M, Müürsepp A. Uusküla A, et al. J Low Genit Tract Dis. 2013 Apr;17(2):129-36. doi: 10.1097/LGT.0b013e3182652213. J Low Genit Tract Dis. 2013. PMID: 23422640

• Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

  Insinga RP, Dasbach EJ, Elbasha EH. Insinga RP, et al. Pharmacoeconomics. 2005;23(11):1107-22. doi: 10.2165/00019053-200523110-00004. Pharmacoeconomics. 2005. PMID: 16277547 Review.

• Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States.

  Chesson HW, Flagg EW, Koutsky L, Hsu K, Unger ER, Shlay JC, Kerndt P, Ghanem KG, Zenilman JM, Hagensee M, Weinstock H, Datta SD. Chesson HW, et al. Vaccine. 2013 Jun 24;31(29):3019-24. doi: 10.1016/j.vaccine.2013.04.051. Epub 2013 May 10. Vaccine. 2013. PMID: 23664991 Free PMC article.

• Management of Precancerous Lesions of the Uterine Cervix according to Demographic Data.

  Modinou O, Liaropoulos L, Kaitelidou D, Kioulafas K, Theodoraki EM. Modinou O, et al. ISRN Obstet Gynecol. 2011;2011:301680. doi: 10.5402/2011/301680. Epub 2010 Oct 27. ISRN Obstet Gynecol. 2011. PMID: 21637358 Free PMC article.

• A Novel Use of Laryngoscope for Difficult Papanicolaou Smear Collection.

  Boudova S, Thomas C, Wolfe J, Schilder JM. Boudova S, et al. Case Rep Obstet Gynecol. 2021 Sep 23;2021:6986768. doi: 10.1155/2021/6986768. eCollection 2021. Case Rep Obstet Gynecol. 2021. PMID: 34603808 Free PMC article.

• Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.

  Chesson HW, Meites E, Ekwueme DU, Saraiya M, Markowitz LE. Chesson HW, et al. Vaccine. 2018 Jul 5;36(29):4362-4368. doi: 10.1016/j.vaccine.2018.04.071. Vaccine. 2018. PMID: 29887325 Free PMC article.

• Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model.

  Baik S, Mehta FF, Chung SH. Baik S, et al. Am J Pathol. 2019 Dec;189(12):2459-2468. doi: 10.1016/j.ajpath.2019.08.013. Epub 2019 Nov 12. Am J Pathol. 2019. PMID: 31732107 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3